• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    F

    Francis Crick Institute

    1,004论文总数
    3.6万引用总数

    The Francis Crick Institute (formerly the UK Centre for Medical Research and Innovation) is a biomedical research centre in London, which was established in 2010 and opened in 2016. The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust. The institute has 1,500 staff, including 1,250 scientists, and an annual budget of over £100 million, making it the biggest single biomedical laboratory in Europe.The institute is named after the molecular biologist, biophysicist, and neuroscientist Francis Crick, co-discoverer of the structure of DNA, who shared the 1962 Nobel Prize for Physiology and Medicine with James Watson and Maurice Wilkins. Unofficially, the Crick has been called Sir Paul's Cathedral, a reference to Sir Paul Nurse and St Paul's Cathedral in London.

    论文量&引用量时间轴

    机构学者

    论文(1004)

    年份
    起
    –
    止
    排序
    1The Phosphoproteomic Landscape of the Neurological Manifestations in Tuberous Sclerosis Complex
    Marie Girodengo, Simeon R. Mihaylov,Katarzyna Klonowska, Laura Mantoan Ritter,Helen R. Flynn, J. Mark Skehel, Elias Bou Farhat,Eleonora Aronica, Matthew White, David J. Kwiatkowski, Sila K. Ultanir,Joseph M. Bateman

    Tuberous sclerosis complex (TSC) is a rare disease caused by mutations in TSC1 and TSC2, resulting in activation of mechanistic target of rapamycin complex 1 (mTORC1). Neurological manifestations in TSC patients include epilepsy, autism and intellectual disability. Two types of brain lesions, cortical tubers and subependymal giant cell astrocytomas (SEGAs), cause the majority of neurological manifestations in TSC. We have limited understanding of the molecular changes that occur in tubers and SEGAs and how these contribute to disease pathogenesis. To investigate this, we performed proteomic and phosphoproteomic analysis of TSC patient tuber and SEGA tissue. Tubers showed evidence of alterations in mitochondrial respiration, cytoskeleton organisation and neuronal function. However, we were unable to detect mTORC1 activation in tubers, likely due to the small number of cells with complete inactivation of TSC1 or TSC2. By contrast, SEGAs showed evidence of strong mTORC1 activation and large-scale changes in the proteome and phosphoproteome. SEGAs exhibited increased expression of ribosomal proteins and activation of a neuroinflammatory response. Phosphoproteomics identified 6060 phosphosites within 2154 proteins increased in SEGAs. Phosphorylation of multiple proteins involved in RNA-metabolism, including mRNA splicing, was increased in SEGAs. Consistent with this, we found evidence of extensive alterations in mRNA transcript splicing in SEGA tissue that is shared with a wide range of cancers. These data greatly expand the repertoire of known mTORC1 target proteins in the human brain and reveal that large-scale mis-regulation of mRNA splicing may promote the formation of SEGAs in TSC.

    2026Acta Neuropathologica(2026)引用:91
    引用
    AI阅读
    加入学术空间
    2Encountering the Unburied Dead: Developments in Mortuary Practice in the Landscape of the Late Bronze Age Megaforts of the Carpathian Basin
    Barry Molloy,Linda Fibiger, Thomas Booth,Dragan Jovanovic,Lidija Milasinovic, Victor Sava, Marija Ljustina,Jovan Koledin, Saoirse Tracy,Dimitra Ermioni Michael

    The treatment of the dead body is a highly social phenomenon, rooted in cultural conventions. Choices in mortuary rites include inhumation, cremation, and excarnation, along with secondary manipulation before or after burial. In the Carpathian Basin between 1600 and 700 b.c., people employed diverse choices in peri- and post-mortem treatment of human remains. Beginning by defining local cremation conventions, including fragmentation of the body, we next present new data to reconstruct excarnation and inhumation practices. These display similar patterns of peri- and post-mortem manipulation in both cemetery and settlement contexts, demonstrating intersections between rites. Engagement with human bones in Late Bronze and Early Iron Age contexts is shown to have been ubiquitous and encompass varying states of integrity, revealing distinct practices surrounding their use or reuse. This shows that human remains, as material culture, played myriad roles in social discourses, ranging from place-making to ancestor reverence to domination of others.

    2026JOURNAL OF FIELD ARCHAEOLOGY(2026)引用:23
    引用
    AI阅读
    加入学术空间
    3RPA Exhaustion Activates SLFN11 to Eliminate Cells with Heightened Replication Stress
    Tyler H. Stanage, Shudong Li,Sandra Segura-Bayona, Aurora I. Idilli, Rhona Millar,Graeme Hewitt, Simon J. Boulton

    SLFN11 is epigenetically silenced and confers chemoresistance in half of all cancers. In response to replication stress, SLFN11 triggers translation shutdown and p53-independent apoptosis, but how DNA damage activates SLFN11 remains unclear. Here through CRISPR-based screens we implicate SLFN11 as the critical determinant of cisplatin sensitivity in cells lacking primase–polymerase (PrimPol)-mediated repriming. SLFN11 and the downstream integrated stress response uniquely promote cisplatin-driven apoptosis in PrimPol-deficient cells. We demonstrate that replication protein A (RPA) exhaustion and single-stranded DNA exposure trigger SLFN11 activation and cell death when PrimPol is inactivated. We further identify the USP1–WDR48 deubiquitinase complex as a positive modulator of SLFN11 activation in PrimPol-deficient cells, revealing an addiction to the Fanconi anaemia pathway to resolve cisplatin lesions. Finally, we demonstrate that rapid RPA exhaustion on chemical inhibition of DNA polymerase α activates SLFN11-dependent cell death. Together, our results implicate RPA exhaustion as a general mechanism to activate SLFN11 in response to heightened replication stress. Stanage et al. identify a role for transfer RNA nuclease SLFN11 in replication-stress-induced cell death in cisplatin-treated cells lacking PrimPol. SLFN11 is activated upon single-stranded DNA accumulation at stalled forks followed by replication protein A exhaustion and cell death.

    2026Nature Cell Biology(2026)引用:5
    引用
    AI阅读
    加入学术空间
    4Gene Regulatory Networks: from Correlative Models to Causal Explanations
    Rory J Maizels,James Briscoe

    Gene regulatory networks (GRNs) explain how the genome controls cellular behaviour and tissue morphogenesis, serving to connect molecular mechanism to functional output. Single-cell technologies now provide descriptions of these networks with unprecedented detail, but this advance has also revealed gene regulatory systems that are too complex for our existing conceptual frameworks. GRNs, which should provide mechanistic explanations, are increasingly reduced to statistical correlations - 'hairballs' that fail to capture molecular causation. Here, we explore why this dilemma exists and propose a path forward. We argue that methods in 'representation learning' can be used to model GRNs, without needing to capture every molecular detail. For this framework, we advocate three linked principles: models must be inherently mechanistic, with structures grounded in cellular and evolutionary biology; molecular principles and constraints must be used to reduce the solution space for learning GRN models; and more sophisticated forms of experimental perturbation and synthetic biological engineering are needed to train models and test predictions. By reimagining GRNs through these principles, we can bridge the gap from data abundance to new conceptual understanding.

    2026Nature reviews Genetics(2026)引用:5
    引用
    AI阅读
    加入学术空间
    5The Promise of GLP-1 Receptor Agonists for Neurodegenerative Diseases
    Dilan Athauda, Nigel H Greig,Wassilios G Meissner,Thomas Foltynie,Sonia Gandhi

    Glucagon-like peptide-1 receptor agonists (GLP-1RAs), established therapies for type 2 diabetes and obesity, are increasingly recognized fortheir potential in neurodegenerative diseases. Preclinical studies across diverse neurodegenerative conditions consistently demonstrate neuroprotective effects of GLP-1RAs, including reduced protein aggregation, enhanced autophagy, improved mitochondrial function, suppression of neuroinflammation, and preservation of synaptic integrity. Epidemiological analyses further suggest reduced incidence of dementia, Parkinson disease, and multiple sclerosis among long-term GLP-1RA users. Early human trials provide signals of target engagement, such as preserved cerebral glucose metabolism, altered inflammatory biomarkers, and slowed brain atrophy, although clinical outcomes to date remain mixed and trials in rarer disorders are sparse. Translation is constrained by uncertainty around optimal molecule choice, CNS penetrance, tolerability, adherence, and heterogeneity of response. Furthermore, next-generation dual and triple agonists may offer enhanced efficacy but remain untested in neurodegeneration. Conceptually, GLP-1RAs share pleiotropic effects with exercise - one of the few interventions with proven disease-modifying potential - by enhancing insulin signaling, stabilizing mitochondria, reducing inflammation, and promoting synaptic plasticity. This overlap highlights their promise as "pharmacological analogues of exercise," and underscores the need for biomarker-driven, disease-specific trials to establish whether GLP-1RAs can deliver durable disease modification across the spectrum of neurodegenerative diseases.

    2026The Journal of clinical investigation(2026)引用:5
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1004 篇论文

    合作机构(100)

    The Francis Crick Institute合作论文 153
    伦敦大学学院合作论文 110
    帝国理工学院合作论文 85
    剑桥大学合作论文 81
    牛津大学合作论文 80
    伦敦国王学院合作论文 52
    伦敦玛丽女王大学合作论文 37
    爱丁堡大学合作论文 28
    惠康桑格研究所合作论文 21
    国王大学合作论文 18

    机构统计